Restart Life Sciences Corp.
HEAL
Classement en actions
#35836
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Prix de l'action
$0.05137558
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$3.21M
Changement (1 jour)
0.00%
Changement (1 an)
78.84%
Pays
CA
Échange Restart Life Sciences Corp. (HEAL)
Catégorie
Healthcare
Ratio P/B pour Restart Life Sciences Corp. (HEAL)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Restart Life Sciences Corp., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Restart Life Sciences Corp. de 2026 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | - |
NL
|
